Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Omalizumab biosimilar by Curateq Biologics for Allergic Asthma: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Curateq Biologics and currently in Phase I for Allergic Asthma. According to GlobalData,...
Omalizumab biosimilar by Curateq Biologics for Nasal Polyps (Nasal Polyposis): Likelihood of Approval
Omalizumab biosimilar is under clinical development by Curateq Biologics and currently in Phase I for Nasal Polyps (Nasal Polyposis). According...
Omalizumab biosimilar by Kashiv BioSciences for Chronic Urticaria Or Hives: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Kashiv BioSciences and currently in Phase III for Chronic Urticaria Or Hives. According...
Omalizumab biosimilar by Synermore Biologics for Rhinosinusitis: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Synermore Biologics and currently in Phase III for Rhinosinusitis. According to GlobalData, Phase...
Omalizumab biosimilar by Teva Pharmaceutical Industries for Chronic Urticaria Or Hives: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Teva Pharmaceutical Industries and currently in Phase III for Chronic Urticaria Or Hives....
Omalizumab biosimilar by Celltrion for Chronic Urticaria Or Hives: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Celltrion and currently in Pre-Registration for Chronic Urticaria Or Hives. According to GlobalData,...
Omalizumab biosimilar by Celltrion for Rhinosinusitis: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Celltrion and currently in Pre-Registration for Rhinosinusitis. According to GlobalData, Pre-Registration drugs for...
Omalizumab biosimilar by Celltrion for Nasal Polyps (Nasal Polyposis): Likelihood of Approval
Omalizumab biosimilar is under clinical development by Celltrion and currently in Pre-Registration for Nasal Polyps (Nasal Polyposis). According to GlobalData,...
Omalizumab biosimilar by Celltrion for Food Allergy: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Celltrion and currently in Pre-Registration for Food Allergy. According to GlobalData, Pre-Registration drugs...
Omalizumab biosimilar by Celltrion for Allergic Asthma: Likelihood of Approval
Omalizumab biosimilar is under clinical development by Celltrion and currently in Pre-Registration for Allergic Asthma. According to GlobalData, Pre-Registration drugs...